Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Idera plans to initiate clinical development of IMO-8400 in two new indications

March 14, 2014

Pluristem Therapeutics reports preclinical data on PLX-PAD cells for tendon injury

March 14, 2014

Safety monitoring board issues positive assessment of phase IIb TNF-Kinoid trial

March 13, 2014

U.S. researchers report development of compositions for rare genetic disease

March 12, 2014

Wright Medical reaches agreement on PMA amendment for Augment Bone Graft

March 11, 2014

Galapagos earns partial milestone payment under osteoarthritis alliance with Servier

March 10, 2014

Xoma will not advance gevokizumab into pivotal program for erosive osteoarthritis of the hand

March 5, 2014

Chinese researchers synthesize new PI3Kdelta inhibitors

Feb. 27, 2014

FDA accepts Xiaflex supplemental BLA submission for review

Feb. 25, 2014

Researchers at Biogen Idec prepare novel autotaxin inhibitors

Feb. 19, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...